Anthrax Dispute Suggests Bioshield Woes

It's the not-so-green secret of the nation's wind-energy boom: Spinning turbines are killing thousands of federally protected birds, including eagles, each year.

Nokia Corp. has unveiled its first Lumia smartphone with a metal cover, low-light camera features and new social network apps. But the new model failed to impress markets, sending the company's stock down.

(Phys.org) —Researchers in Britain have announced the development of a new strain of wheat that early reports suggest produce 30 percent greater yields than those currently in use.

Aereo, the startup that offers television stations over the Internet starting at $8 a month, says it will start service in Atlanta on June 17.

An international team of scientists, including a University of York researcher, has carried out ground-breaking experiments to investigate the atomic structure of astatine (Z=85), the rarest naturally occurring ...

Northwestern University scientists have struck gold in the laboratory. They have discovered an inexpensive and environmentally benign method that uses simple cornstarch—instead of cyanide—to isolate gold from raw materials ...

Europe's medicines watchdog said Friday the benefits of acne drug Diane-35, also widely used as a contraceptive, outweigh the risk of developing blood clots in the veins—when correctly prescribed.

Singapore's Agency for Science, Technology and Research (A*STAR) and Switzerland's Cytos Biotechnology AG today announced that the first healthy volunteer has been dosed in a Phase 1 clinical trial with their ...

(Medical Xpress)—An aspirin a day may not always keep heart disease away, say two University of Florida cardiologists. But a new algorithm they have developed outlines factors physicians should weigh as ...

(HealthDay)—The U.S. Food and Drug Administration has approved new, lower-dose labeling for the popular sleep drug Ambien (zolpidem) in an effort to cut down on daytime drowsiness that could be a hazard ...

(HealthDay)—Simponi (golimumab) injection has been approved by the U.S. Food and Drug Administration to treat adults with moderate-to-severe ulcerative colitis.

The Food and Drug Administration says it approved a genetic test from Roche to help doctors identify patients who can benefit from a lung cancer drug made by Genentech.